UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
402.19
-6.55 (-1.60%)
At close: Aug 11, 2026, 4:00 PM EDT
402.50
+0.31 (0.08%)
Pre-market: Aug 12, 2026, 8:02 AM EDT

UnitedHealth Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
361,004299,080462,862486,458495,188472,514
Market Cap Growth
58.62%-35.38%-4.85%-1.76%4.80%42.43%
Enterprise Value
405,747306,668472,795496,621503,763477,233
Last Close Price
402.19330.11505.86526.47530.18502.14

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
25.8924.9532.6222.0725.0327.77
Forward PE
18.9019.5517.3519.4222.0324.18
PEG Ratio
1.482.651.161.731.571.61
PS Ratio
0.800.671.161.311.531.64
PB Ratio
3.703.185.005.486.376.58
P/FCF Ratio
15.2918.6122.3618.9421.1623.76
P/OCF Ratio
13.3615.1819.1216.7418.9021.15

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
0.900.691.181.341.551.66
EV/EBITDA Ratio
15.6313.1512.9913.6715.8217.63
EV/EBIT Ratio
18.7216.1714.6415.3517.7219.91
EV/FCF Ratio
17.1819.0822.8319.3421.5223.99

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Asset Turnover
1.451.471.401.431.421.40
Return on Equity (ROE)
14.36%12.54%15.13%24.98%25.35%24.12%
Return on Assets (ROA)
5.99%5.44%8.57%9.91%9.73%9.30%
Return on Invested Capital (ROIC)
17.54%16.18%24.34%27.77%27.36%25.92%
Return on Capital Employed (ROCE)
7.00%6.24%11.29%12.46%12.42%11.71%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
3.91%4.01%3.07%4.53%3.99%3.60%
FCF Yield
6.54%5.37%4.47%5.28%4.73%4.21%
Dividend Yield
2.31%2.64%1.62%1.38%1.21%1.12%
Payout Ratio
59.74%65.66%52.29%30.21%29.03%29.78%
Buyback Yield / Dilution
1.47%1.94%0.96%1.26%0.63%0.52%
Total Shareholder Return
3.77%4.58%2.58%2.65%1.83%1.64%
SEC Filings: 10-K · 10-Q